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Background: The majority of viruses enter host cells via endocytosis. Current knowledge of viral entry pathways is
largely based upon infectivity measurements following genetic and/or pharmacological interventions that disrupt
vesicular trafficking and maturation. Imaging of single virus entry in living cells provides a powerful means to
delineate viral trafficking pathways and entry sites under physiological conditions.
Results: Here, we visualized single avian retrovirus co-trafficking with markers for early (Rab5) and late (Rab7)
endosomes, acidification of endosomal lumen and the resulting viral fusion measured by the viral content release
into the cytoplasm. Virus-carrying vesicles either merged with the existing Rab5-positive early endosomes or slowly
accumulated Rab5. The Rab5 recruitment to virus-carrying endosomes correlated with acidification of their lumen.
Viral fusion occurred either in early (Rab5-positive) or intermediate (Rab5- and Rab7-positive) compartments.
Interestingly, different isoforms of the cognate receptor directed virus entry from distinct endosomes. In cells
expressing the transmembrane receptor, viruses preferentially entered and fused with slowly maturing early
endosomes prior to accumulation of Rab7. By comparison, in cells expressing the GPI-anchored receptor, viruses
entered both slowly and quickly maturing endosomes and fused with early (Rab5-positive) and intermediate
(Rab5- and Rab7-positive) compartments.
Conclusions: Since the rate of low pH-triggered fusion was independent of the receptor isoform, we concluded
that the sites of virus entry are determined by the kinetic competition between endosome maturation and viral
fusion. Our findings demonstrate the ability of this retrovirus to enter cells via alternative endocytic pathways and
establish infection by releasing its content from distinct endosomal compartments.
Keywords: Avian sarcoma and leukosis virus, Single particle tracking, Acid-induced virus fusion, Fusion kinetics,
Fusion pore, Endosome maturation, Rab proteinsBackground
Many pathogens, including enveloped and non-enveloped
viruses, use distinct endocytic pathways to infect their host
cells [1-4]. Viral entry routes have been traditionally stud-
ied by blocking one or more endocytic pathways and/or
preventing endosome maturation (reviewed in [4]). These
strategies include pharmacological interventions, silencing
the expression of proteins involved in vesicular trafficking
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article, unless otherwise stated.The main limitation of these approaches is that they often
have off-target effects by altering key cellular functions.
For instance, agents that raise endosomal pH block entry
of viruses whose fusion is triggered by acidic conditions,
but can also interfere with pH-independent steps of viral
entry [5-7] due to the coupling between endosome matur-
ation and acidification of their lumen [8-11]. Another
widely used approach to elucidate the viral entry pathways
is based on virus colocalization with endosomal cargo or
markers for specific intracellular compartments in fixed
cells. This approach suffers from poor spatial resolution
(optical microscopy) or lack of information regarding spe-
cific proteins (conventional electron microscopy). Although
immunogold labeling and super-resolution fluorescencentral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
Padilla-Parra et al. Retrovirology 2014, 11:47 Page 2 of 14
http://www.retrovirology.com/content/11/1/47imaging address these issues, the fact that the majority of
viruses fails to establish infection and can thus be traf-
ficked through non-productive pathways limits the utility
of these approaches.
The pioneering work by A. Helenius, X. Zhuang and
others introduced real-time single virus tracking in live
cells to delineate their entry pathways [12-18]. When
combined with imaging of formation and maturation of
endosomal compartments, single particle tracking is a
powerful means to define the sites of virus entry
[14,15,19-21]. Furthermore, single particle tracking and
detection of virus-endosome fusion provides the much
needed evidence for productive entry culminating in
the release of viral genome [19,22,23]. Visualization of
the influenza virus co-trafficking with markers for early
(Rab5) and late (Rab7) endosomes [8-10,24], along with
detection of the lipid mixing step of viral fusion, revealed
that this virus preferentially enters a subset of quickly ma-
turing vesicles and fuses with maturing endosomes [19].
Imaging of Dengue virus co-trafficking with Rab5- and
Rab7-positive endosomes suggests that the virus initiates
lipid mixing in late endosomes [14], which have been
implicated as sites of Dengue entry [14,21,25].
While the lipid mixing activity is a convenient readout
for membrane fusion, strictly speaking, lipid mixing dem-
onstrates the progression to a hemifusion stage, which is
defined as the merger of contacting leaflets without the
formation of a fusion pore [26,27]. There are, however, ex-
amples of hemifusion not culminating in complete viral
fusion or infection [6,23,25,28-32]. Thus, lipid mixing
alone, without the detection of a viral content release into
the cytoplasm may not reveal the actual entry sites into
cells. This consideration highlights the importance of
detecting complete viral fusion as it occurs in endosomes
to pinpoint the sites of virus entry.
We have developed virus labeling and time-resolved
imaging techniques to track single virus movement in
cells and visualize full fusion events [22,23,30,33-36]. In
these experiments, fusion is detected based on the viral
content release, which is a proxy for productive entry. The
Avian Sarcoma and Leukosis Virus (ASLV) requires two
consecutive triggers/cues to undergo fusion – priming
by cognate receptors on the cell surface and low pH-
dependent fusion in endosomes [33,37,38]. The robust
fusion with endosomes mediated by ASLV Env and the
ability to control and synchronize these events [34,35,39,40]
make ASLV a valuable model system for studies of viral
entry. In addition, the subgroup A virus (ASLV-A) can
effectively utilize two alternatively spliced isoforms of
its TVA receptor, TVA800 (GPI-anchored receptor) and
TVA950 (transmembrane receptor) [41,42]. Importantly,
accumulating evidence implies that these TVA isoforms
direct ASLV-A entry through alternative endocytic
pathways [22,34,35,39].Simultaneous pH measurements in virus-carrying
vesicles and imaging of the resulting content release
from single ASLV-A pseudoviruses showed that fusion
occurred at pH around 6.0 [36]. The mildly acidic pH
typical for early endosomes [43] suggests that ASLV-A
enters cells from these compartments. Here, we expli-
citly tested this conjecture by visualizing ASLV-A co-
trafficking and fusion with intracellular compartments
tagged with fluorescent Rab5 and Rab7 proteins, the
canonical markers for early and late endosomes, re-
spectively (e.g. [8,19,44]). Single virus imaging showed
that ASLV-A fused with compartments positive for Rab5
alone or both Rab5 and Rab7, thus demonstrating that the
virus can enter cells from both early or intermediate (ma-
turing) compartments, respectively. Interestingly, ASLV-A
preferentially fused with early endosomes in cells express-
ing TVA950, while it was equally likely to fuse with early
and intermediate endosomes in cells expressing TVA800.
The predominant entry from early endosomes in TVA950
cells was not due to the faster kinetics of low pH-
dependent fusion in these cells compared to cells ex-
pressing TVA800. The transmembrane receptor appears
to direct ASLV-A to slowly maturing endosomes where
fusion tends to occur prior to accumulation of Rab7. By
contrast, the nearly identical rates of fusion and endo-
some maturation appear to control non-selective ASLV-
A fusion with early and intermediate compartments in
TVA800 cells. These findings show that ASLV-A can
enter cells from distinct intracellular compartments and
that the sites of entry are determined by the receptor
isoforms. To our knowledge, this is the first direct dem-
onstration of complete virus fusion with specific endo-
somal compartments, using time-resolved single virus
imaging in living cells.
Results
Visualization of single virus co-trafficking with endosomal
markers and viral content release
We have previously visualized single virus entry and fu-
sion with cells using particles containing a genetically
encoded releasable content marker [22,23,30,33-36].
Viral fusion leads to the loss of fluorescence signal
owing to the dilution of a fluorescent marker in the
cytoplasm. To eliminate false-positive events due to the
particle deviation from the focal plane, viruses were co-
labeled with a reference marker incorporated either into
the viral membrane or into the core. This enables reli-
able detection of fusion based upon disappearance of a
viral content marker, but not of a non-releasable refer-
ence marker.
In order to identify the point of virus entry into a cell,
one needs to simultaneously image double-labeled vi-
ruses in cells co-expressing fluorescent markers for
early (Rab5) and late (Rab7) endosomes. Such 4-color
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the spectral overlap between fluorescent proteins and
poor signal/background ratio in single virus experiments.
We therefore imaged the viral content release from single-
labeled particles (without a reference marker) following
their entry into intracellular compartments labeled with
fluorescent Rab5 and Rab7 (Figure 1A). Here, fluorescent
Rabs bound to virus-carrying endosomes serve as refer-
ence signals for reliable detection of the loss of viral con-
tent upon fusion. Coordinated virus movement with
puncta positive for either Rab5 or Rab7 greatly diminishes
the possibility of virus disappearance through departure
from the focal plane or sudden lateral movements. Follow-
ing the convention (e.g. [8,19]), we operationally define
early endosomes as Rab5+/Rab7−, intermediate/maturing
endosomes as Rab5+/Rab7+, and late endosomes as
Rab5−/Rab7+ compartments.
ASLV-A appears to be internalized through different
endocytic pathways in cells expressing the TVA800 or
TVA950 isoforms [22,34,35,39]. We therefore hypothe-
sized that these receptor isoforms direct virus entry from
distinct compartments. To test this hypothesis, we visual-
ized entry and fusion of content-labeled ASLV-A pseudo-
viruses into CV-1 cells stably expressing either TVA800 or
TVA950 receptor [35] and co-transfected with CFP-Rab5
and YFP-Rab7. In order to minimize the disruptive effects
of Rab overexpression which leads to the formation of
aberrantly large endosomes (e.g., [19,45] and Figure 1B,
yellow contour), only cells expressing low to moderate
levels of both markers (Additional file 1: Figure S1)
were selected for analysis. These cells exhibited punc-
tate Rab5 and Rab7 fluorescence pattern, which enabled
the visualization of virus co-trafficking with these com-
partments (Figure 1). Quantitative analysis showed that
the Rab5 and Rab7 expression levels in TVA800 and
TVA950 cells selected for imaging the virus fusion were
statistically identical and significantly lower than in
transfected cells excluded from analyses (Additional file 1:
Figure S1).
Pseudoviruses were visualized by incorporating the
Gag-mKate2 chimera, which yielded free mKate2 protein
trapped within the viral envelope upon virus maturation,
thus enabling the detection of virus-endosome fusion
[36]. Viral particles were bound to cells by spinoculation
at 4°C. Virus input was adjusted, so that equal number of
pseudoviruses attached per each TVA800 and TVA950 cell
(10 ± 3 and 10 ± 6 particles, respectively, P = 0.8). ASLV-A
uptake and fusion were initiated by quickly raising the
temperature to 37°C. Virus co-trafficking with endosomes
was defined as a >80% overlap between the particle and
one or both endosomal markers for 5 or more consecu-
tive images, during which time the particle traveled at
least 1 μm (for details, see Methods and Additional
file 2: Figure S2).TVA isoforms mediate ASLV-A entry from distinct
endosomal compartments
We found that the majority of cell-bound pseudoviruses
co-trafficked with endosomal markers in TVA800 and in
TVA950 cells (Figure 1 and Additional file 3: Figure S3).
The remainder of particles did not meet the co-trafficking
criterion, perhaps due to their delayed uptake and/or
undetectably low amounts of fluorescent Rabs on some
intracellular compartments. Entry of mKate2-labeled
pseudoviruses (red) into early CFP-Rab5+ (blue) endo-
somes and then into intermediate compartments posi-
tive for both CFP-Rab5 and YFP-Rab7 (green) was
manifested in pseudocolor changes from red to purple
(red/blue) and, in some cases, from purple to whitish
(red/blue/green, Figure 1B-E and Additional files 4 and 5:
Movies S1 and S2).
At least two patterns of Rab5 acquisition were ob-
served – merger with an existing Rab5+ endosome
(Figure 1B,C and Additional files 6 and 7: Figures. S4A
and S5A) and gradual accumulation of this marker
(Figure 1D,E and Additional files 6 and 7: Figures S4B
and S5B). Abrupt acquisition of Rab5 was seen for 15
out of 22 fusing particles in TVA950 cells and for 9 out
of 18 fusing particles in TVA800 cells. However, this
difference in the mode of endosome maturation between
the two cell lines was not significant (P = 0.243). The pat-
tern of Rab7 accretion was similar to that of Rab5: step-
wise appearance due to fusion between virus-carrying
vesicles with Rab5+/Rab7+ endosomes (Additional file 6:
Figure S4A) or gradual accumulation (Figure 1D,E,
Additional file 6: Figure S4B and Additional file 7:
Figure S5A-C). Abrupt vs. gradual acquisition of Rab7
by endosomes harboring fusion-competent viruses was
equally likely to occur in either cell line: 7 out of 18
(TVA800) and 12 out of 22 events (TVA950, P = 0.554).
Almost 50% of pseudoviruses residing in Rab5+ or
Rab5+/Rab7+ compartments underwent fusion, as evi-
denced by the release of viral content into the cytosol
(Additional file 3: Figure S3). We observed ASLV-A fusion
in both early and intermediate compartments (Figure 1).
However, in TVA950 cells, content release typically oc-
curred from early endosomes before detectable accumu-
lation of Rab7 (Figure 1B,C and Additional file 6:
Figure S4C), whereas fusion with TVA800 cells oc-
curred in both early and intermediate compartments
(Figure 1D,E and Additional file 7: Figure S5C). As
shown in Figure 2A, a significantly greater fraction of
pseudoviruses fused with early Rab5+/Rab7− endosomes
in TVA950 cells (n = 22) compared to TVA800 cells (n =
18, P = 0.033 based on the χ2 test). Notably, irrespective of
the TVA isoform, all fusion events occurred in Rab5+
compartments – either early or intermediate endosomes.
We next asked whether the reason for the preferential
ASLV-A fusion with early endosomes in TVA950 cells
Figure 1 ASLV-A trafficking and fusion with early and intermediate endosomes. (A) Illustration of ASLV-A (Gag-mKate2-labeled, red) fusion
with early endosomes (CFP-Rab5+, blue) and intermediate endosomes (YFP-Rab7+, green). Changes in pseudocolor upon virus entry and fusion
with these endosomes are illustrated by small circles. (B-E) Fusion of Gag-mKate2-labeled ASLV-A (red) with TVA950 (B, C) and TVA800 (D, E) cells
co-transfected with CFP-Rab5 (blue) and YFP-Rab7 (green). Viruses were pre-bound to cells in the cold and their internalization and fusion were
initiated by shifting to 37°C. Panels B and C illustrate ASLV-A fusion with an early endosome of a TVA950 cell and panels D and E show fusion
with an intermediate endosome of a TVA800 cell. The boxed areas in B and D are enlarged in the image panels below. Yellow contour in B marks
highly fluorescent perinuclear area. (C, E) The fluorescence intensities of viral and endosomal markers as a function of time were obtained by
single particle tracking. The mKate2 channel was used to track particles before they colocalized with CFP-Rab5, and the CFP channel was used for
particle tracking afterwards. The gradual decrease of the mKate2 signal preceding the final drop to the background level (panels C and E) was
likely caused by the particle deviation from the focal plane, but not by photobleaching (see Additional files 4 and 5: Figures S4 and S5). mKate2
release is marked by arrowheads in C and E. The viral content release in C occurred in two steps, suggesting transient closure of a nascent fusion
pore [22,34]. An arrow in panel E marks the appearance of the YFP-Rab7 signal. The colored horizontal bars above the graphs show the pseudocolor
changes associated with virus colocalization and fusion with early or intermediate endosomes.
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Figure 2 Analysis of the extent and kinetics of ASLV-A fusion with endosomes of cells expressing alternative TVA isoforms. (A) The
distributions of ASLV-A fusion with early and intermediate endosomes in TVA950 (n = 15) and TVA800 (n = 16) cells, as determined by single particle
tracking (see Figure 1 for details). (B) Kinetics of ASLV-A fusion with TVA800 and TVA950 cells following the virus entry into early endosomes. The time
intervals from appearance of the CFP-Rab5 signal to release of the viral content (tFusion – tRab5) were measured and plotted as cumulative distributions.
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entry into early endosomes as compared to TVA800
cells. The kinetics of pseudovirus fusion was assessed by
measuring the lag time between the Rab5 acquisition
and viral fusion (tFusion - tRab5, Figure 2B). This analysis
revealed that the post-Rab5 acquisition kinetics of fusion
with TVA800 and TVA950 cells were indistinguishable.
Thus, the preferential ASLV-A entry from early endo-
somes of TVA950 cells could not be explained by faster
fusion compared to TVA800 cells. The above results im-
plicate slower maturation of virus-carrying endosomes
in TVA950 cells as the reason for the predominant con-
tent release from early endosomes.
ASLV-A enters from slowly maturing endosomes in
TVA950-expressing cells
The existence of distinct pools of endosomes, differing
in their maturation rates and mobility has been reported
previously [19]. In this study, maturation of early endo-
somes has been defined as the time interval between the
appearance of Rab5 and Rab7 signals (tRab7 – tRab5). We
also used the conversion time from early to intermediate
compartments as a measure of the rate of maturation ofvirus-carrying endosomes. For fusion events occurring
after the appearance of the Rab7 signal, particle tracking
was performed using the mKate2 channel (Figure 1),
whereas the time of endosomal maturation for fusion
events preceding the Rab7 accumulation was obtained by
tracking the Rab5 channel (Figure 3A-D and Additional
files 8 and 9: Movies S3 and S4). The maturation times of
virus-harboring endosomes were significantly slower in
TVA950 compared to TVA800 cells (Figure 3E, P < 0.02).
This finding demonstrates that ASLV-A preferentially en-
ters from slowly maturing compartments in TVA950 cells,
whereas this virus appears equally distributed between
slowly and quickly maturing endosomes in TVA800 cells.
Taken together, our results imply that the slower mat-
uration kinetics of ASLV-A-containing endosomes in
TVA950 cells accounts for the preferential fusion with
early endosomes (Figure 2A).
ASLV-A entry into late endosomes is delayed
Pseudoviruses that co-trafficked with endosomal markers,
but did not fuse, enabled the visualization of ASLV-A trans-
port to the perinuclear space. Almost without exception,
unfused viruses resided in Rab5+/Rab7+ compartments of
Figure 3 Post-fusion maturation of ASLV-A-carrying endosomes. (A, B) ASLV-A (red) fusion with an early (CFP-Rab5+) endosome followed by
heterotypic fusion with an intermediate (CFP-Rab5+/YFP-Rab7+) endosome in a TVA950 cell marked by arrows in panels A and B. The last image
panel shows the virus trajectory colored according to the color changes corresponding to entry into an early endosome, virus fusion and then
heterotypic fusion with another endosome. Scale bar 10 μm. (C, D) ASLV-A (red) fusion with an early (CFP-Rab5+, blue) endosome of a TVA800
cell followed by acquisition of YFP-Rab7 (green). The last image panel shows the virus trajectory colored according to the color changes corresponding
to entry into an early endosome, virus fusion and then heterotypic fusion with another endosome. Scale bar 5 μm. (B, D) The points of mKate2 release
are marked by arrowheads. The vertical dashed lines mark the acquisition of the above-threshold Rab7 signal. The colored horizontal bars above the
graphs reflect the pseudocolor changes associated with virus colocalization and fusion with early or intermediate endosomes. (E) The maturation
kinetics for endosomes carrying fusion-competent ASLV-A pseudoviruses in TVA800 and TVA950 cells. The lag times between accumulation of Rab5
and Rab7 signals (tRab7 – tRab5) were measured, as described in Methods and plotted as cumulative distributions. To aid comparison, the kinetics of
ASLV-A fusion after entry into Rab5+ endosomes (tFusion – tRab5) are re-plotted from Figure 2B (respectively colored dashed lines).
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ments. This was because virus-carrying intermediate endo-
somes did not lose Rab5 for as long as we could track them
(Figure 1, Additional files 6 and 7: Figures S4 and S5, and
Additional file 10: Movie S5), except for one particle in a
TVA800 cell (Additional file 7: Figure S5A). Considering
that the formation of late endosomes is associated withloss of Rab5 [9,10,24,46], our results indicate that virus-
carrying compartments do not fully mature. The lack of
full endosome maturation could be due to subversion/
disruption of normal endosomal trafficking by ASLV-A.
Alternatively, the brightly fluorescent perinuclear area
(e.g., yellow contour in Figure 1B) could mask the loss
of Rab5 following the virus entry into late endosomes.
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acidification of endosomal lumen
As indicated above, all viral fusion events (disregarding
those that did not colocalize with any endosomal
markers) occurred within Rab5+ spots, i.e. in early or
intermediate endosomes (Figures 1, 2, 3). We thus sim-
plified the imaging experiment by expressing only
Rab5 as a reference marker, which allowed the usage of
pseudoviruses co-labeled with Gag-mKate2 (the content
marker) and EcpH-ICAM (the membrane marker).
EcpH-ICAM consists of the pH-sensitive GFP variant,
ecliptic pHluorin [47], fused to the transmembrane do-
main of human ICAM-1 [48]. The incorporation of
EcpH-ICAM into the viral membrane enables the
visualization of virus entry into mildly acidic compart-
ments based on the loss of the EcpH signal [48,49]. In
these experiments, we expressed Rab5 tagged with an
orange fluorescent protein mKO [50].
In order to elucidate the relationship between the
Rab5 accumulation, endosome acidification and viral
fusion, particles co-labeled with EcpH-ICAM (green)
and Gag-mKate2 (red) were allowed to enter target
cells transfected with mKO-Rab5 (pseudocolored blue,
Figure 4A). Entry of double-labeled particles, which
appear yellow (Figure 4B,C) into pH-neutral Rab5+
endosomes (blue) was not associated with the loss of
the EcpH signal, resulting in a transient whitish appear-
ance (not shown). However, virus/Rab5 colocalization
without the nearly concomitant loss of the EcpH signal
was very brief: the EcpH fluorescence vanished at the
time or shortly after Rab5 acquisition, as manifested by
the pseudocolor change from yellow or whitish to purple
(Figure 4B-E and Additional files 11 and 12: Movies
S6 and S7).
Single particle tracking revealed tight correlation be-
tween the appearance of Rab5 and acidification of endo-
somal lumen in both TVA800 and TVA950 cells. The
overall kinetics of the Rab5 accumulation and endo-
some acidification were superimposable for both TVA
isoforms (Figure 5A, P > 0.830). In agreement with our
previous results [22], the kinetics of ASLV-A entry into
acidic endosomes of TVA950 cells was considerably fas-
ter than in TVA800 cells (P = 0.005), reflecting the fas-
ter rate of virus uptake through the transmembrane
receptor. Analysis of the lag times between Rab5 ap-
pearance and acidification for individual virus-carrying
endosomes confirmed that these events occurred within
a narrow time window (Figure 5B), in good agreement
with the previous study [19]. In most cases, we were un-
able to resolve the lag time between the appearance of
Rab5 and disappearance of EcpH signals; the longest
delay between the two events was around 60 sec. The
distribution of these lag times for TVA800 and TVA950
cells was nearly identical (P = 1.0).The kinetics of low pH-dependent ASLV-A fusion with
endosomes is independent of TVA isoforms
In spite of the faster kinetics of entry into acidic com-
partments in TVA950 cells (Figure 5A), the distribution
of lags between endosome acidification and viral fusion
for each particle was not affected by the TVA isoform
(Figure 5C). The acid-induced ASLV-A fusion in TVA800
and TVA950 cells occurred with half-times of 2.2 and
3.2 min, respectively, but the difference between two
distributions was not statistically significant. This result
is in agreement with our previous measurements of the
true kinetics of ASLV-A fusion with TVA-expressing
CV-1 cells [36] and with the kinetics of fusion following
the virus entry into Rab5+ endosomes (Figure 2B). Our
findings further support the notion that preferential
ASLV-A fusion with early endosomes of TVA950 cells is
due to delayed endosome maturation (compare Figures 2B,
3E and 5C). By contrast, the comparable rates of endo-
some maturation and of low pH-dependent virus fusion in
TVA800 cells are most likely responsible for the non-
selective entry from early and intermediate compartments
in these cells.
Discussion
Single particle tracking in living cells has revealed that
the influenza and Dengue viruses undergo lipid mixing
in intermediate and late endosomes, respectively [14,19].
Here, we employed single particle imaging combined
with the detection of viral content release into the cyto-
plasm to define the intracellular sites of ASLV-A entry.
These studies showed that ASLV-A releases its content
from early or intermediate endosomes, depending on the
receptor isoform. Since at least a fraction of full fusion
events leads to infection, these findings delineate product-
ive entry pathways of this retrovirus. To our knowledge,
this is the first direct demonstration of single virus fu-
sion with specific endosomal compartments using time-
resolved live cell imaging.
We found that, unlike the influenza virus, which is
sorted to quickly maturing endosomes [19], ASLV-A
preferentially enters slowly maturing vesicles in cells
expressing TVA950. The virus enrichment in slowly
maturing endosomes, combined with the relatively fast
rate of low pH-dependent virus fusion, ensures pre-
dominant entry from early compartments. By contrast,
indiscriminate entry into different pools of vesicles in
TVA800 cells results in ASLV-A fusion with both slowly
and quickly maturing endosomes. Thus, considering that
the Rab5 accumulation and acidification of endosomal
lumen are tightly correlated (Figure 5B,C) and that the
rate of low pH-dependent ASLV-A fusion is not affected
by the receptor isoform (Figure 5C), the sites of entry
are likely determined by the kinetic competition between
endosome maturation and virus fusion. This notion is
Figure 4 Single ASLV-A entry into acidic endosomes and virus-endosome fusion. (A) A diagram illustrating the visualization of the
endosomal pH drop and subsequent ASLV-A fusion. (B-E) ASLV-A (yellow) fusion with TVA950 (B, C) and TVA800 (D, E) cells transiently expressing
mKO-Rab5 (blue). Pseudoviruses were labeled with EcpH-ICAM (green) and Gag-mKate2 (red). Virus internalization and fusion were initiated by
shifting to 37°C at t = 0. (B, D) The right top image panels show consecutive snapshots of the enlarged boxed areas showing the virus prior to
internalization (left), immediately after entry into acidic Rab5-positive endosomes (middle) and after fusion with early endosomes (right). The
graphs in panel C and E show the fluorescence intensities of mKO-Rab5 and the viral EcpH-ICAM (green) and Gag-mKate2 (red) signals as a
function of time. The disappearance of the EcpH signal tended to occur concomitantly with ASLV-A/Rab5 colocalization (raise in the mKO signal).
Single particle tracking was performed using the mKate2 channel before colocalization with mKO-Rab5, and using the mKO channel afterward.
The colored horizontal bars above the graphs in C and E reflect the pseudocolor changes associated with entry of double-labeled particle into
Rab5+ endosomes, lumen acidification and fusion.
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maturation in TVA800 cells and considerably slower
rate of maturation in TVA950 cells (Figure 3E).
Of note, since a large fraction of pseudoviruses did not
co-traffic with either Rab5 or Rab7 (Additional file 3:
Figure S3), we cannot rule out the existence of analternative ASLV-A entry pathway that bypasses Rab5- or
Rab7-containing compartments. We consider this possi-
bility unlikely because: (a) a relatively weak fluorescence
signal from ectopically expressed Rab5/Rab7 limits our
ability to detect small number of these markers on individ-
ual endosomes against the high fluorescence background;
Figure 5 Kinetics of ASLV-A entry into Rab5 positive endosomes,
acidification and fusion. (A) Distribution of waiting times from
raising the temperature (t = 0) to colocalization of double-labeled
ASLV-A particles with the mKO-Rab5 signal (triangles) and
distribution of waiting times for disappearance of the EcpH signal
due acidification of endosomal lumen, (circles) in TVA800 (red/dark
red) and in TVA950 (green/dark green) cells. (B) Histogram of the
time intervals between Rab5 colocalization and EcpH quenching
(tAcid – tRab5) in TVA800 and TVA950 cells. (C) Kinetics of
double-labeled ASLV-A pseudovirus fusion measured as the time
interval between the EcpH quenching (acidification) and loss of the
mKate2 signal (fusion) in TVA800 and TVA950 cells.
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in order to eliminate spurious colocalization events; (c)
the overwhelming majority of non-co-trafficking particles
did not exhibit considerable mobility (data not shown)
and or lose their content marker, suggesting the lack of
entry/fusion activity. These particles thus appear to be
non-functional, perhaps devoid of a requisite number of
Env glycoproteins.
The above results are in excellent agreement with the
predicted sites of ASLV-A entry based on analysis of
single particle mobility. We have found that ASLV-A
preferentially enters less mobile endosomes in TVA950
cells as compared to TVA800 cells [36]. Considering
that endosome mobility tends to correlate with their
maturation rate [8,19], we surmised that less mobile
virus-harboring compartments corresponded to slowly
maturing endosomes. The current study confirmed the
correlation between endosome mobility and maturation
and demonstrated that ASLV-A and influenza virus have
opposite preferences for quickly vs. slowly maturing pools
of vesicles. The mechanism of ASLV-A entry into a slowly
maturing pool of endosomes in TVA950 cells is currently
not understood. Within its cytoplasmic tail, the trans-
membrane receptor contains two DxF motifs recognized
by the AP-2 adaptor, which directs membrane proteins to
clathrin-coated pits [51]. It appears, however, that AP-2
does not selectively directs cargo to slowly vs. quickly
maturing endosomes, as has been demonstrated for
transferrin [36]. It is thus possible that TVA950 non-
selectively enters both pools of endosomes, but, because
the majority of endosomes are maturing slowly (65%,
[36]), most receptor molecules (and therefore most vi-
ruses) end up in the latter compartments. In other
words, the apparent ASLV-A sorting to slowly maturing
endosomes could simply occur through non-selective
TVA950 uptake into these compartments. Future studies
of TVA800 and TVA950 endocytosis will help delineate
the mechanism of selective ASLV-A entry from distinct
intracellular compartments.
Endosomal maturation is accompanied by profound
changes in their content and membrane composition
[9]. These changes are exploited by some viruses to
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appears to undergo lipid mixing in early endosomes,
but requires lyso-bisphosphatidic acid, an unusual lipid
concentrated in late endosomes, to undergo full fusion
and initiate infection [25]. By contrast, ASLV-A appears
to efficiently fuse with both early and intermediate
endosomes. The nearly identical fusion kinetics with
distinct compartments (Figure 5C), suggests that the lag
from endosome acidification to the viral content release
is determined by the Env refolding downstream of the
receptor priming and low pH-dependent steps [37,38]
and not by endosome composition. Interestingly, how-
ever, the fraction of pseudoviruses that fused with acidic
endosomes was somewhat greater in TVA800 cells
compared to TVA950 cells (30% vs. 20%, Table 1). This
result indicates that the efficiency of ASLV-A fusion
could be affected by the properties of different intracel-
lular compartments. For simplicity, we have not consid-
ered here different endosome maturation phenotypes
observed in live cell imaging experiments. Consistent
with another study [8], at least two maturation patterns
were observed for endosomes harboring the virus –
gradual accretion of endosomal markers vs. merger with
the existing early or intermediate endosomes. It would
be interesting to carefully investigate the fate of viruses
being routed through different maturation programs.
Another interesting observation is that, under our con-
ditions, ASLV-A particles, even those that did not undergo
fusion, did not appear to enter late (Rab5−/Rab7+) endo-
somes. Non-fusing pseudoviruses co-trafficked with com-
partments that did not fully mature in either TVA800 or
TVA950 cells for as long as we could track them. Not-
withstanding the technical difficulties related to tracking
viral particles in highly fluorescent perinuclear area, this
result indicates a possible subversion of normal endosomal
maturation by ASLV-A. This notion is consistent with
the remarkable ability of this virus to retain its fusion
competency after a prolonged co-culture with cells in
the presence of NH4Cl, which blocks virus fusion by
raising endosomal pH [34,35,39].
The ASLV-A’s ability to infect cells by fusing with early
endosomes shows that the retroviral core can get to the
nucleus all the way from the cell periphery. By analogyTable 1 Analysis of ASLV-A entry into and fusion with
acidic endosomes






TVA800 37 11 29.7
TVA950 45 9 20.0
ASLV-A pseudoviruses co-labeled with EcpH-ICAM and Gag-mKate2 were
allowed to enter and fuse with TVA800 or TVA950 cells. The number of particles
undergoing fusion (mKate2 release) was determined and normalized to the
number of particles entering acidic compartments (EcpH quenching).to HIV-1 [17], retrograde trafficking of the ASLV-A core
is likely mediated by cytoskeleton. Replicative advantages
conferred by the ASLV-A fusion with early endosomes,
as opposed to late endosomes, which bring the virus
closer to the nucleus, are currently not clear. Perhaps
early escape from endosomes minimizes the chances for
virus degradation. Regardless of the reasons for entry
from early or intermediate compartments, it is apparent
that post-fusion transport of viral cores to the nuclear
membrane occurs quite efficiently. Moreover, under cer-
tain conditions, retroviral cores can cross the endosomal
membrane and enter the cytoplasm. We have obtained
evidence that, following the transient NH4Cl arrest, the
HIV-1 cores pseudotyped ASLV-A Env can be delivered
into vacuoles through low pH-dependent fusion [35].
Remarkably, these cores escaped from vacuoles via a yet
unknown temperature-dependent process, perhaps akin
to back-fusion of intralumenal vesicles with the limiting
membrane of multivesicular bodies [6]. Back-fusion has
been implicated in entry of diverse enveloped viruses
[6,52]. Future studies of the retroviral core transport
from different cellular locations to the nucleus should
shed light on the host factors that are essential for
infection.
Conclusions
Through the visualization of ASLV-A fusion with intra-
cellular compartments tagged by fluorescent markers for
early and late endosomes, we pinpointed the sites of
viral entry and demonstrated that these sites are regu-
lated by the naturally occurring isoforms of the cognate
receptor. Whereas the transmembrane receptor favored
ASLV-A fusion with early endosomes, the GPI-anchored
isoform directed the viral fusion to intermediate endo-
somes without delaying the low pH-mediated fusion.
The ability to enter from distinct intracellular compart-
ments is conferred by preferential ASLV-A entry into
slowly maturing endosomes in cells expressing the
transmembrane receptor. Our results also suggest that
ASLV-A inhibits maturation of intermediate compart-
ments into late endosomes, perhaps to avoid degrad-
ation and maximize the fusion efficiency. These findings
provide new insights into retroviral entry pathways and
their regulation by cognate receptors.
Methods
Cell lines and plasmids
HEK 293 T/17 cells were obtained from ATCC (Manassas,
VA) and passaged as described elsewhere [35]. CV-1 cells
expressing high levels of the TVA receptor isoforms,
CV-1/TVA800 and CV-1/TVA950, have been described
previously [35]. The ASLV-A envelope glycoprotein lack-
ing the cytoplasmic domain [33], and MLV Gag-mKate2
and EcpH-ICAM constructs [35,48] have been described
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LTR lacZ [53] were obtained from Dr. W. Mothes (Yale
University), and the pECFP-C1-Rab5 and pEYFP-C1-
Rab7 expression vectors [19] were a gift from Dr. X.
Zhuang (Harvard University).
Construction of mKO-Rab5 expression vector
To construct mKO-Rab5 expression vector, mKO gene
was amplified by PCR using pmKO-MN1 (Amalgaam
MBL, Tokyo, Japan) as template, the forward primer
containing AgeI restriction site (italicized) 5’-CTACC
GGTCGCCACCATGGTGAGTGTGATTAAAC-3’ and
the reverse primer containing HindIII restriction site
(underlined sequence): 5’ – CGAAGCTTGGAATGAG
CTACTGCATCTTCTAC-3’. The amplified fragment
was cloned into pCR4blunt-topo vector using TOPO
cloning kit (Invitrogen, Grand Island, NY). After verifi-
cation of the mKO sequence, the mRFP sequence in the
mRFP-Rab5 vector (Addgene, Cambridge, MA) was re-
placed with the mKO fragment using AgeI and HindIII
restriction sites.
Virus preparation
Fluorescent pseudoviruses were produced in HEK 293
T/17 cells using PolyFect Transfection reagent (Qiagen,
Valencia, CA). Cells grown on a 10 cm dish were trans-
fected with 2 μg MLV-Gag-Pol, 1 μg MLV Gag-mKate2,
3 μg pMLV-LTR-LacZ and 3 μg of the cytoplasmic tail-
truncated ASLV-A Env. To introduce a pH-sensor into
the viral membrane, 3 μg of EcpH-ICAM-encoding
plasmid was added to the DNA transfection mixture.
Virus-containing medium was collected 48 h post-
transfection, passed through a 0.45 μm filter, aliquoted
and stored at −80°C. The infectious titer was determined
by a β-galactosidase assay in CV-1 cells expressing
TVA800, as described previously [23]
Transient expression of tagged endosomal markers
2∙105 CV-1 cells stably expressing either TVA950 or
TVA800 receptors were seeded on 35 mm Petri dishes
(Mattek, Ashland, Massachusetts) in phenol red-free
DMEM the day before transfection. On the next day,
80% confluent cells were transfected with 0.5 μg of each
CFP-Rab5 and YFP-Rab7 plasmids or mKO-Rab5, using
Nanofectin transfection reagent (PAA Laboratories,
Dartmouth, MA). The cells were used for imaging 24 h
post-transfection.
Imaging virus entry into acidic compartments and fusion
CV-1/TVA950 or CV-1/TVA800 cells transfected with
either CFP-Rab5 and YFP-Rab7 or mKO-Rab5 were
placed on ice, washed with cold Hank’s buffer (HBSS),
and centrifuged with ~1.5 · 104 IU of single labeled with
Gag-mKate2 pseudoviruses or particles co-labeled withEcpH-ICAM and Gag-mKate2, respectively, at 2,100 × g
(4°C) for 20 min. Unbound viruses were removed by
washing, cells were mounted onto a microscope stage
maintained at 37°C. Once a suitable image field was
chosen, virus internalization and fusion were initiated by
adding 1 ml of warm HBSS and imaged using a Zeiss
LSM 780 confocal microscope (Zeiss Microsystems, Jena,
Germany) with a 63×/1.4 NA oil immersion objective.
Images were acquired every 8–12 sec for ~60 min. The
axial position of a specimen during acquisition was stabi-
lized using the Definite Focus module. Cells overexpress-
ing the endosomal markers and/or containing aberrant
swollen endosomes were excluded from analysis.
EcpH and mKate2 were excited with the 488 and
561 nm laser lines, respectively. CFP-Rab5 and YFP-Rab7
were excited with 458 nm and 514 nm lines, respectively,
whereas the 543 nm line was used for mKO-Rab5. Fluor-
escence emission was detected with the 32-channel GaAsP
spectral detector. In experiments with the single labeled
virus (Gag-mKate2) entering cells co-transfected with
CFP-Rab5 and YFP-Rab7, the first 16 channels recorded
the CFP signal and the remaining 16-channels acquired
the YFP emission signal, the mKate2 fluorescence was de-
tected using a cooled PMT. When using double-labeled
viruses (EcpH-ICAM and Gag-mKate2) and cells ex-
pressing mKO-Rab5, the first 16 channels of the GaAsP
detector were allocated for the EcpH signal and the
remaining 16 channels for the mKO signal, while the
mKate2 signal was acquired with the cooled PMT. The
emission windows for the fluorescent proteins utilized
where selected as follows: CFP (465–500 nm), EcpH
(500–540 nm), YFP (520–560 nm), mKO (550–585 nm)
and mKate2 (600–650 nm). Spectral unmixing was ap-
plied, as necessary, to correct for bleed-through between
the CFP and YFP channels and between the EcpH and
mKO channels. The above imaging conditions ensured
negligible bleed through between CFP and YFP channels
(e.g., Figures 1C and 3B).
Image analyses
Single virus tracking was performed with Imaris (BitPlane,
Switzerland) or Volocity (Perkin Elmer, MA) software.
Both single- (Gag-mKate2) and double-labeled (EcpH-
ICAM and Gag-mKate2) viruses that entered the cell
and colocalized with early endosomes (decorated with
CFP-Rab5 or mKO-Rab5, depending on the experiment)
were tracked using the red channel. The acquisition of
Rab5 or Rab7 by virus-carrying endosomes was defined
as the point when the endosomal marker signal exceeded
the background level by 30%. Virus-endosome colocaliza-
tion analysis was carried out with ImageJ (http://imagej.
nih.gov/ij/). A line histogram that showed normalized in-
tensity profiles of the viral and endosomal markers. The
percentage of overlap between the profiles was obtained
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Viruses showing at least 80% overlap with endosomal
markers during >5 consecutive frames and traveled at least
1 μm were considered as co-trafficking with endosomes.
After viruses colocalized with endosomal markers for 5
consecutive frames additional tracking was performed,
using the CFP-Rab5 signal or the mKO-Rab5 signal as a
reference, as indicated. Fusion was detected as disappear-
ance of the red signal (Gag-mKate2 release) whilst the
Rab5 signal remained steady. In some cases, quickly trav-
eling endosomes co-localized with the virus were tracked
manually using the Volocity software. These analyses
yielded the mean fluorescence intensity of viral and endo-
somal markers, as well as their coordinates, as a function
of time. Statistical analysis of the kinetics data was per-
formed using a two-tailed t-test or Rank Sum test, and
fraction of viruses fused in cells expressing TVA800 and
TVA950 cells was analysed using a χ2 test (SigmaPlot, San
Jose, CA).
Additional files
Additional file 1: Figure S1. Quantification of Rab5 and Rab7
expression in transiently transfected TVA800 and TVA950 cells. Mean CFP-
Rab5 (A) and YFP-Rab7 (B) fluorescence of individual transfected TVA800
and TVA950 cells (both selected and excluded from virus fusion analyses)
was determined by selecting regions of interest comprising the whole
cell using ImageJ. The background signal was subtracted and spectral
bleed-through was eliminated, as described in Methods. The statistical
significance of mean fluorescence values for TVA800 and TVA950 cells are
shown above the plots.
Additional file 2: Figure S2. Determination of virus-endosome
colocalization. Line histograms show normalized local maxima for mKate2
(the viral content marker, red) and CFP-Rab5 (blue), as the viral particle
merged with an early, CFP-Rab5+ endosome. A >80% overlap of areas
under line histograms constituted virus-endosome colocalization.
Subsequent virus fusion is manifested in the loss of the mKate2 signal
(t = 660 s).
Additional file 3: Figure S3. Fraction of ASLV-A pseudoviruses
cotrafficking with Rab markers and fusing with endosomes. The number
of single-labeled (Gag-mKate2) ASLV-A pseudoviruses that co-trafficked
with either CFP-Rab5 or YFP-Rab7 and the number of particles that
co-trafficked with these markers and released their mKate2 content (i.e.,
fused) is shown for TVA800 and TVA950 cells. Virus-endosome colocalization
was determined, as described in Methods and illustrated in Figure S2.
Results of 6 independent experiments for each cell line are shown. Note
that the loss of the mKate2 signal from single-labeled viruses which did
not colocalize with endosomal markers could not be unambiguously
interpreted as fusion. These events could also represent particle
detachment from cells or the inability to reliably track particles that shift
large distances between consecutive image frames.
Additional file 4: Movie 1. Single ASLV-A pseudovirus fusion with an
early endosome of a TVA950 cell. Fusion of pseudovirus labeled with
Gag-mKate2 (red) with TVA950 cells was detected in a CFP-Rab5+
endosomal compartment (blue) with no detectable YFP-Rab7 signal
(green). The movie is played at 5 frames/sec (40 x speeds). For details,
see Figure 1B.
Additional file 5: Movie 2. Single ASLV-A pseudovirus fusion with a
maturing endosome in a TVA800 cell. Pseudovirus containing the
Gag-mKate2 (red) marker co-traffics with a Rab5+ (blue) endosome and
enters a maturing Rab5+/Rab7+ (blue/green) endosome prior to fusion.
Parallel windows showing a combination of red/green/blue (RGB), red/blue (RB) and red/green (RG) channels are shown side-by-side to better
illustrate ASLV-A colocalization with markers of early (CFP-Rab5) and late
(YFP-Rab7) endosomes. The movie is played at 5 frames/sec (40 x
speeds); the frame rate is slower at the end of the movie to better re-
solve the disappearance of the mKate2 signal. Scale bar for the zoomed
region of interest is 4 μm. For details, see Figure 1D.
Additional file 6: Figure S4. Examples of Rab5 and Rab7 accumulation
by ASLV-A pseudovirus-carrying endosomes in TVA950 cells. ASLV-A
pseudoviruses labeled with Gag-mKate2 (red) were pre-bound in the cold
to TVA950 cells co-expressing CFP-Rab5 (blue) and YFP-Rab7 (green), and
their entry/fusion was initiated by raising the temperature at t = 0. (A, B)
Particles that did not undergo fusion accumulate in Rab5+/Rab7+
compartments. Right panels show the fluorescence intensities of viral
(Gag-mKate2) and endosomal (CFP-Rab5 and YFP-Rab7) markers obtained
by single particle tracking. The Rab5 and Rab7 accumulation occurred
either through an abrupt increase of the Rab5 and Rab7 signals upon
virus entry into pre-existing endosomes (A) or by gradual accumulation
of these markers (B). An intermediate endosome that fuses with virus-
bearing endosome at t ~14 min is marked by an arrowhead in panel A.
Scale bars are 3 μm (A) 5 μm (B). (C) Fluorescence intensities showing
ASLV-A fusion with an early endosome. Sudden appearance in the Rab5
signal is due to fusion with the existing Rab5+ endosome.
Additional file 7: Figure S5. Examples of Rab5 and Rab7 accumulation
by ASLV-A pseudovirus-carrying endosomes in TVA800 cells. ASLV-A
pseudoviruses labeled with Gag-mKate2 (red) were pre-bound in the cold
to TVA800 cells co-expressing CFP-Rab5 (blue) and YFP-Rab7 (green), and
their entry/fusion was initiated by raising the temperature at t = 0. (A, B)
Images and intensity profiles for non-fusing particles that co-traffic with
Rab5+ and Rab+/Rab7+ endosomes, as determined by single virus
tracking. The Rab5 and Rab7 accumulation occurred either in a stepwise
fashion (A, an early endosome fusing with virus-carrying compartment is
shown by an arrowhead) or by gradual accumulation (B). Scale bars are
2 μm (A) and 5 μm (B). (C) Fluorescence intensities upon ASLV-A fusion
with an early Rab5+ endosome. CFP-Rab5 is gradually accumulated in the
virus-carrying endosome.
Additional file 8: Movie 3. ASLV-A fusion with an early endosome in a
TVA950 cell and subsequent endosome maturation. Shortly ASLV-A
pseudovirus content (Gag-mKate2, red) release occurred from an early,
CFP-Rab5+ (blue) compartment, endosome maturation ensued, as
evidenced by raise of the YFP-Rab7 (green) signal. The movie is played at
5 frames/sec (40x speed). For more information, see Figure 3A.
Additional file 9: Movie 4. ASLV-A fusion with an early endosome in a
TVA800 cell and subsequent endosome maturation. ASLV-A pseudovirus
(red) fusion with a TVA800 cell occurs in a highly mobile CFP-Rab5+
compartment (blue), followed by a gradual increase of the YFP-Rab7+
signal (green). Scale bar 5 μm (first frames). The movie is played at 2
frames/sec (16x speed). For more information, see Figure 3C.
Additional file 10: Movie 5. Non-fusing ASLV-A pseudovirus traffics
through early endosomes and enters intermediate compartments in
TVA950 cells. Following the internalization of with ASLV-A pseudoviruses
containing Gag-mKate2 (red) by TVA950 cells transiently co-expressing
CFP-Rab5 (blue) and YFP-Rab7 (green), the virus enters Rab5+ and then
Rab5+/Rab7+ endosomes. The movie is played at 5 frames/sec (40x speed).
Additional file 11: Movie 6. ASLV-A entry into an early endosome and
concomitant acidification of endosomal lumen in TVA950 cell. ASLV-A
pseudovirus co-labeled with Gag-mKate2 (red) and EcpH-ICAM (green)
enters the early mKO-Rab5+ endosome (blue) in a TVA950 cell. Due to
colocalization of three colors virus-endosome complex appears whitish
(arrow). Soon after virus entry, the endosome becomes acidic, as
evidenced by the loss of the EcpH-ICAM signal (purple particle), which in
turn leads to ASLV-A content release into the cytosol (blue particle). The
frame rate is slower around the very brief interval between acidification
and fusion. The movie is played at 5 frames/sec (40x speed). For more
information, see Figure 4B.
Additional file 12: Movie 7. ASLV-A entry into an early endosome and
concomitant acidification of endosomal lumen in TVA800 cell. ASLV-A
pseudovirus co-labeled with Gag-mKate2 (red) and EcpH-ICAM (green)
enters the early mKO-Rab5+ endosome (blue) in a TVA950 cell. Due to
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(arrow). Soon after virus entry, the endosome becomes acidic, as
evidenced by the loss of the EcpH-ICAM signal (purple particle), which in
turn leads to ASLV-A content release into the cytosol (blue particle). Scale
bar for the zoomed region of interest is 5 μm. The movie is played at 5
frames/sec (40x speed). For more information, see Figure 4D.
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